ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

STX Shield Therapeutics Plc

1.925
0.175 (10.00%)
Last Updated: 14:37:30
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.175 10.00% 1.925 1.85 2.00 1.925 1.75 1.75 2,813,745 14:37:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.37 14.89M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.75p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £14.89 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.37.

Shield Therapeutics Share Discussion Threads

Showing 22751 to 22775 of 23300 messages
Chat Pages: Latest  920  919  918  917  916  915  914  913  912  911  910  909  Older
DateSubjectAuthorDiscuss
03/1/2024
16:44
One of the few that's up 2day. I hold a full position so not adding anyway.
napoleon 14th
03/1/2024
15:14
It wants to run this one. I suspect the seller is out and they are just waiting orders to market to take it up.
the imperialist
02/1/2024
10:56
I'm not sure that breakeven is just around the corner... Probably 9-12 months away... Luckily Mr Market typically looks 12 months ahead :-) I'm happy as long as it's clear that the milestones towards breakeven are being hit!Onwards and upwards before the next Q4/FY TU - possibly in late January but more likely in mid/late Feb, based on the Q3 TU.
cyberbub
02/1/2024
09:48
20p and 37p handles come after the test of 13p IMHO. I don't follow the fundamentals, but am always interested in potential catalysts when a chart screams BUY! If I was a betting man I'd say the 'breakeven' news is just around the corner. When it lands....whoosh!

DYOR as always.

the imperialist
02/1/2024
09:44
Good start to the new year as the share price breaks out of the trading range we've been stuck in for the past couple of months.
parob
02/1/2024
08:43
"Shield Therapeutics plc (LON:STX) Is Expected To Breakeven In The Near Future"

That's all I needed....

the imperialist
29/12/2023
12:27
On the way to 13p. See you there next month.
the imperialist
29/12/2023
12:03
Added a few today.
rafboy
29/12/2023
11:54
Looking good again :)
z1co
27/12/2023
15:48
I expect the share price to be comfortably above 7p before the next update.
z1co
22/12/2023
08:07
Trying for a little Christmas top up but nt with HL at 6.5
parob
21/12/2023
15:10
I have no anger here. I managed many in my past and the behavior of this CEO sticks out like a sore thumb and has done since he took the chair. I held on to hope i was wrong but i was not. This guy has no share price mindset and never will. I accept i learned my lesson and the 1m stock i have i could not care less about so aim to be pragmatic in my view to help others.

We can also dance around numbers on an improving share but reality was it need to hit its lowest value for that to happen. HOWEVER, even in this setting the CEO is under performing against 1yr old statistics that cost half the cash burn then.

Is it worth a punt at 6p - YES because even this idiot CEO will get dragged up or booted out by AOP or TVRS

bolitix
21/12/2023
07:24
It's moving up to test the last structure. That's how markets move. 13p incoming. Might take a week, might take a month, but it's coming.

Sit back, and chill. (or stick a limit in for 12p).

DYOR as always.

the imperialist
21/12/2023
07:19
Higher low formed on chart. Let's hope it can push on over the next few trading days. Haven't seen any 1M sales in a while so I think the large seller has gone, it's smaller PI sells that have held this back recently.
parob
20/12/2023
16:13
No quote available to buy even 50,000 at 6.50p

Another tick up likely before the close

z1co
20/12/2023
16:05
Bolitix I fear you're losing visibility of the opportunity due to your anger.Of course the sales team by themselves won't be enough to hit targets! Remember that not every prescription is sold directly by the sales team! The opportunity comes from getting doctors firstly aware of the product, and secondly prescribing the product! Once they're convinced that it works then they will not only continue to prescribe it to increasing numbers of patients, but they will tell their colleagues about it, and it turns into a virtuous circle! After 2025 they will be able to start ramping down the sales team, and then see what happens to profitability!We know the product works. We know doctors are starting to prescribe (and re-prescribe) it. So the question is purely whether sales ramp up enough, including the GTN ratio, to overcome costs. Personally I think they have a decent chance of doing it, or at least of making good enough progress that they could raise another few mills as a stopgap at a much higher share price I don't have a crystal ball though.
cyberbub
20/12/2023
15:19
I too believe in the product and what it can do for those poor characters who need it.

The day this CEO clown took over my heart dropped as every word he uttered sounded so superficial. The board also need to go for setting a 75+p target for his shares yet paid him once it dropped 10 fold under his chairing.

He needs to hit a 42k sales target 4Q23 to be on par pro-rata 3Q23. He needs to hit that per month to achieve his 2025 agenda so no hope there without doubling his useless staff and costs. Anyone can hit targets he set but at what cost - he has not explained this!!

My thinking and hope is he will list on the US exchange by then so best thing for a share shot in the arm

bolitix
20/12/2023
14:52
Can't get an online quote for a fairly modest buy. Anyone else having the same problem?
husbod
20/12/2023
07:50
The chart clearly shows a return to the 13p area over the next few weeks. Don't let the opinions of bedwetters cloud your judgement.

Note: A bid comes, and we could be north of a big number in a single session.

the imperialist
20/12/2023
07:42
There are clearly still significant risks here, we all know that, or else we would be at 50p already... It's a horse race between the overheads and the revenues... At the moment it looks as if the revenues are coming up on the outside, but there's no guarantee they won't stumble and have to be shot... Ultimately you pays your money you makes your choice...
cyberbub
20/12/2023
07:29
Bolitix Your comments are legitimate but as with most message boards posters can not accept anything negative.
Maybe it’s the fact they are under pressure financially who Knows but there as been lots of contradictory comments from the CEO.
I’ve always believed in the product but the next two updates are crucial any disappointment with the outrageous running costs and it’s possibly the end of the very painful journey

best1467
19/12/2023
20:38
holding to end25!!
bolitix
19/12/2023
16:59
Just as the price ticked up on the way to 13p.

What a mug.

the imperialist
19/12/2023
16:51
Bolitix have you sold out by any chance? :-))
cyberbub
19/12/2023
15:28
Would anything have been better if Tim Watts was running the show?
daveboy19
Chat Pages: Latest  920  919  918  917  916  915  914  913  912  911  910  909  Older

Your Recent History

Delayed Upgrade Clock